BUTENAFINE HYDROCHLORIDE

BUTENAFINE HYDROCHLORIDE was reported 595 times

These side effects are most commonly reported by patients taking BUTENAFINE HYDROCHLORIDE:

# Side effect Count
0 DRUG INEFFECTIVE 189
1 OFF LABEL USE 59
2 PRODUCT USE ISSUE 44
3 PRODUCT USE IN UNAPPROVED INDICATION 34
4 PRURITUS 33
5 CONDITION AGGRAVATED 29
6 RASH 23
7 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 20
8 DRUG EFFECT DECREASED 19
9 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 19
10 ERYTHEMA 19
11 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 15
12 BURNING SENSATION 12
13 PAIN 12
14 PRODUCT PRESCRIBING ISSUE 12
15 SKIN IRRITATION 12
16 APPLICATION SITE PAIN 11
17 ACCIDENTAL EXPOSURE TO PRODUCT 10
18 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 9
19 DRUG ADMINISTERED AT INAPPROPRIATE SITE 9
20 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 9
21 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 9
22 EXPIRED PRODUCT ADMINISTERED 8
23 INCORRECT DRUG ADMINISTRATION DURATION 8
24 NAUSEA 8
25 BLISTER 7
26 DIARRHOEA 7
27 DRY SKIN 7
28 HYPERSENSITIVITY 7
29 SKIN EXFOLIATION 7
30 THERAPEUTIC RESPONSE UNEXPECTED 7
31 UNEVALUABLE EVENT 7
32 APPLICATION SITE ERYTHEMA 6
33 DIZZINESS 6
34 FATIGUE 6
35 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6
36 INCORRECT PRODUCT ADMINISTRATION DURATION 6
37 INSOMNIA 6
38 PAIN IN EXTREMITY 6
39 PARAESTHESIA 6
40 PERIPHERAL SWELLING 6
41 RASH ERYTHEMATOUS 6
42 ANXIETY 5
43 DISTURBANCE IN ATTENTION 5
44 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 5
45 DRUG PRESCRIBING ERROR 5
46 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5
47 RASH PAPULAR 5
48 SKIN BURNING SENSATION 5
49 SKIN DISCOLOURATION 5
50 ASPARTATE AMINOTRANSFERASE INCREASED 4
51 BACK PAIN 4
52 DEPRESSION 4
53 DYSPNOEA 4
54 EXTRA DOSE ADMINISTERED 4
55 FULL BLOOD COUNT DECREASED 4
56 HEADACHE 4
57 INCORRECT DOSE ADMINISTERED 4
58 NAIL DISORDER 4
59 POLLAKIURIA 4
60 PRODUCT QUALITY ISSUE 4
61 SKIN DISORDER 4
62 TINEA CRURIS 4
63 WEIGHT DECREASED 4
64 ABDOMINAL DISCOMFORT 3
65 ABDOMINAL PAIN UPPER 3
66 ACNE 3
67 ALANINE AMINOTRANSFERASE INCREASED 3
68 APPLICATION SITE PRURITUS 3
69 ARTHRALGIA 3
70 ASTHENIA 3
71 BLOOD CREATININE INCREASED 3
72 DECREASED APPETITE 3
73 DISCOMFORT 3
74 DRUG EFFECT INCOMPLETE 3
75 DYSPEPSIA 3
76 EXPIRED DRUG ADMINISTERED 3
77 FEBRILE NEUTROPENIA 3
78 FUNGAL INFECTION 3
79 HYPOAESTHESIA 3
80 INCORRECT DOSAGE ADMINISTERED 3
81 MUSCLE TWITCHING 3
82 MYALGIA 3
83 PRODUCT LOT NUMBER ISSUE 3
84 PYREXIA 3
85 RASH PRURITIC 3
86 THERAPEUTIC PRODUCT EFFECT DELAYED 3
87 URTICARIA 3
88 VOMITING 3
89 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 2
90 ANAEMIA 2
91 APPLICATION SITE DISCOMFORT 2
92 APPLICATION SITE IRRITATION 2
93 APPLICATION SITE VESICLES 2
94 BLOOD LACTATE DEHYDROGENASE INCREASED 2
95 BLOOD PRESSURE DECREASED 2
96 BLOOD PRESSURE INCREASED 2
97 CEREBRAL INFARCTION 2
98 CHEST PAIN 2
99 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 2
100 CONFUSIONAL STATE 2
101 CONSTIPATION 2
102 DEATH 2
103 DRUG EFFECT LESS THAN EXPECTED 2
104 DRUG HYPERSENSITIVITY 2
105 DRY MOUTH 2
106 FEELING ABNORMAL 2
107 FLUSHING 2
108 GAIT DISTURBANCE 2
109 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2
110 GASTROINTESTINAL HAEMORRHAGE 2
111 GINGIVAL DISORDER 2
112 HAEMATURIA 2
113 HEPATIC FUNCTION ABNORMAL 2
114 HOT FLUSH 2
115 HYPERHIDROSIS 2
116 INFECTION 2
117 INFLAMMATION 2
118 INTENTIONAL PRODUCT MISUSE 2
119 IRRITABILITY 2
120 LYMPHOCYTE COUNT DECREASED 2
121 MALAISE 2
122 MATERNAL EXPOSURE DURING PREGNANCY 2
123 NASOPHARYNGITIS 2
124 ORAL DISCOMFORT 2
125 ORAL PAIN 2
126 PHARYNGITIS 2
127 PLATELET COUNT DECREASED 2
128 PNEUMONIA 2
129 PRODUCT DOSE OMISSION ISSUE 2
130 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2
131 PRODUCT LABEL CONFUSION 2
132 PRODUCT LABEL ISSUE 2
133 PRODUCT PHYSICAL ISSUE 2
134 PRURITUS GENERALISED 2
135 RED BLOOD CELL COUNT DECREASED 2
136 RETCHING 2
137 SINUSITIS 2
138 SKIN ABRASION 2
139 SKIN REACTION 2
140 THERAPEUTIC PRODUCT INEFFECTIVE 2
141 THERMAL BURN 2
142 THINKING ABNORMAL 2
143 TINEA INFECTION 2
144 TOOTH DISORDER 2
145 TREMOR 2
146 UPPER RESPIRATORY TRACT INFECTION 2
147 WHITE BLOOD CELL COUNT DECREASED 2
148 ABASIA 1
149 ABDOMINAL DISTENSION 1
150 ABDOMINAL STRANGULATED HERNIA 1
151 ABNORMAL BEHAVIOUR 1
152 ACIDOSIS 1
153 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1
154 ACTIVITIES OF DAILY LIVING IMPAIRED 1
155 ADVERSE EVENT 1
156 ADVERSE REACTION 1
157 AFFECTIVE DISORDER 1
158 ALOPECIA 1
159 AMNESIA 1
160 ANAL FISTULA 1
161 ANAL HAEMORRHAGE 1
162 ANGER 1
163 ANHEDONIA 1
164 APPLICATION SITE BURN 1
165 APPLICATION SITE DERMATITIS 1
166 APPLICATION SITE DISCOLOURATION 1
167 APPLICATION SITE DRYNESS 1
168 APPLICATION SITE PARAESTHESIA 1
169 APPLICATION SITE RASH 1
170 APPLICATION SITE REACTION 1
171 APPLICATION SITE SWELLING 1
172 APPLICATION SITE WARMTH 1
173 ARTERIOSPASM CORONARY 1
174 ARTHRITIS 1
175 ATRIAL FIBRILLATION 1
176 ATYPICAL FRACTURE 1
177 AUTOMATIC BLADDER 1
178 BASAL CELL CARCINOMA 1
179 BLADDER PAIN 1
180 BLOOD ALKALINE PHOSPHATASE INCREASED 1
181 BLOOD AMYLASE INCREASED 1
182 BLOOD CREATINE INCREASED 1
183 BLOOD CREATINE PHOSPHOKINASE INCREASED 1
184 BLOOD FIBRINOGEN DECREASED 1
185 BLOOD PHOSPHORUS DECREASED 1
186 BLOOD POTASSIUM DECREASED 1
187 BLOOD URIC ACID INCREASED 1
188 BLOOD URINE PRESENT 1
189 BODY TINEA 1
190 BONE DEMINERALISATION 1
191 BREAST ENLARGEMENT 1
192 BREAST PAIN 1
193 BRONCHITIS 1
194 BURNS THIRD DEGREE 1
195 C-REACTIVE PROTEIN INCREASED 1
196 CANDIDA INFECTION 1
197 CARDIAC ARREST 1
198 CARDIAC FAILURE 1
199 CARPAL TUNNEL SYNDROME 1
200 CHEMICAL INJURY 1
201 CHEST DISCOMFORT 1
202 CHILLS 1
203 CHOLELITHIASIS 1
204 CHRONIC KIDNEY DISEASE 1
205 COAGULOPATHY 1
206 COGNITIVE DISORDER 1
207 COLON CANCER 1
208 CONTRAINDICATED PRODUCT ADMINISTERED 1
209 COUGH 1
210 COVID-19 1
211 CROHN^S DISEASE 1
212 CRYING 1
213 CYTOMEGALOVIRUS TEST POSITIVE 1
214 DECREASED ACTIVITY 1
215 DEPENDENCE 1
216 DEVELOPMENTAL HIP DYSPLASIA 1
217 DIAPHRAGMATIC PARALYSIS 1
218 DRUG EFFECT INCREASED 1
219 DRUG INTERACTION 1
220 DRUG LEVEL BELOW THERAPEUTIC 1
221 DRUG RESISTANCE 1
222 DRUG SCREEN POSITIVE 1
223 DRUG WITHDRAWAL SYNDROME 1
224 DYSPHORIA 1
225 DYSPNOEA EXERTIONAL 1
226 EAR INFECTION 1
227 EAR INFECTION BACTERIAL 1
228 EAR SWELLING 1
229 EATING DISORDER 1
230 ECONOMIC PROBLEM 1
231 ECZEMA ASTEATOTIC 1
232 ELECTROCARDIOGRAM Q WAVE ABNORMAL 1
233 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1
234 ELECTROLYTE IMBALANCE 1
235 EMOTIONAL DISTRESS 1
236 ERECTILE DYSFUNCTION 1
237 EXFOLIATIVE RASH 1
238 EYE PAIN 1
239 EYE PRURITUS 1
240 FALL 1
241 FIBRIN D DIMER INCREASED 1
242 FIBRIN DEGRADATION PRODUCTS INCREASED 1
243 FIBROMYALGIA 1
244 FLASHBACK 1
245 GASTRITIS 1
246 GASTROENTERITIS 1
247 GENITAL BURNING SENSATION 1
248 GENITAL INFECTION FUNGAL 1
249 GENITAL SWELLING 1
250 GENITAL TRACT INFLAMMATION 1
251 GROIN PAIN 1
252 HAEMORRHAGE 1
253 HAEMORRHOIDAL HAEMORRHAGE 1
254 HAEMORRHOIDS 1
255 HELICOBACTER INFECTION 1
256 HEPATITIS B 1
257 HERPES ZOSTER 1
258 HERPES ZOSTER OTICUS 1
259 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 1
260 HYPERTENSION 1
261 HYPOAESTHESIA ORAL 1
262 HYPOKALAEMIA 1
263 ILLNESS 1
264 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1
265 INADEQUATE ANALGESIA 1
266 INCONTINENCE 1
267 INCORRECT ROUTE OF DRUG ADMINISTRATION 1
268 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1
269 INFLAMMATION OF LACRIMAL PASSAGE 1
270 INFLAMMATORY PAIN 1
271 INFLUENZA LIKE ILLNESS 1
272 INTENTIONAL PRODUCT USE ISSUE 1
273 INTERNATIONAL NORMALISED RATIO INCREASED 1
274 JAUNDICE 1
275 JAUNDICE NEONATAL 1
276 KNEE OPERATION 1
277 KYPHOSIS 1
278 LARGE INTESTINE PERFORATION 1
279 LARYNGITIS 1
280 LEUKOCYTOSIS 1
281 LIBIDO DECREASED 1
282 LIMB MASS 1
283 LOCAL SWELLING 1
284 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1
285 LUMBAR SPINAL STENOSIS 1
286 LYMPHADENOPATHY 1
287 MASKED FACIES 1
288 MATERNAL EXPOSURE BEFORE PREGNANCY 1
289 MEDICATION ERROR 1
290 MENTAL DISORDER 1
291 MICTURITION URGENCY 1
292 MIDDLE INSOMNIA 1
293 MIGRAINE 1
294 MOBILITY DECREASED 1
295 MOOD SWINGS 1
296 MUSCLE SPASMS 1
297 MUSCULAR WEAKNESS 1
298 MUSCULOSKELETAL STIFFNESS 1
299 MYOCARDIAL INFARCTION 1
300 NAIL DISCOLOURATION 1
301 NAIL INFECTION 1
302 NAIL INJURY 1
303 NAIL PIGMENTATION 1
304 NERVOUSNESS 1
305 NEUTROPENIA 1
306 NEUTROPHIL COUNT DECREASED 1
307 NO ADVERSE EVENT 1
308 OCULAR DISCOMFORT 1
309 OROPHARYNGEAL PAIN 1
310 PAIN OF SKIN 1
311 PALPITATIONS 1
312 PAPULE 1
313 PARAESTHESIA ORAL 1
314 PARANOIA 1
315 PELVIC INFECTION 1
316 PELVIC PAIN 1
317 PERIPHERAL COLDNESS 1
318 PHARMACEUTICAL PRODUCT COMPLAINT 1
319 PHARYNGEAL OEDEMA 1
320 PHARYNGEAL STENOSIS 1
321 PLEURAL EFFUSION 1
322 POOR QUALITY DRUG ADMINISTERED 1
323 POST PROCEDURAL HAEMORRHAGE 1
324 POST PROCEDURAL INFECTION 1
325 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1
326 PRODUCT COMPLAINT 1
327 PRODUCT EXPIRATION DATE ISSUE 1
328 PRODUCT ODOUR ABNORMAL 1
329 PRODUCT PACKAGING ISSUE 1
330 PRODUCT PHYSICAL CONSISTENCY ISSUE 1
331 PRODUCT PRESCRIBING ERROR 1
332 PRODUCT SELECTION ERROR 1
333 PRODUCT USE COMPLAINT 1
334 PRODUCT USED FOR UNKNOWN INDICATION 1
335 PROSTATIC SPECIFIC ANTIGEN INCREASED 1
336 PROSTATITIS 1
337 PRURITUS GENITAL 1
338 PSORIATIC ARTHROPATHY 1
339 PURPURA 1
340 QUALITY OF LIFE DECREASED 1
341 RASH MACULAR 1
342 READING DISORDER 1
343 REBOUND EFFECT 1
344 RENAL FAILURE 1
345 RENAL FAILURE CHRONIC 1
346 RENAL PAIN 1
347 RESPIRATORY ARREST 1
348 RESPIRATORY FUME INHALATION DISORDER 1
349 ROAD TRAFFIC ACCIDENT 1
350 ROCKY MOUNTAIN SPOTTED FEVER 1
351 SARS-COV-2 TEST POSITIVE 1
352 SCROTAL ERYTHEMA 1
353 SEPTIC SHOCK 1
354 SEROTONIN SYNDROME 1
355 SERRATIA INFECTION 1
356 SINUS DISORDER 1
357 SINUSITIS FUNGAL 1
358 SKIN EROSION 1
359 SKIN ODOUR ABNORMAL 1
360 SKIN ULCER 1
361 SLEEP DISORDER 1
362 SPINAL FRACTURE 1
363 SPINAL OPERATION 1
364 SPONTANEOUS HAEMORRHAGE 1
365 SQUAMOUS CELL CARCINOMA 1
366 STARING 1
367 STRANGULATED INCISIONAL HERNIA 1
368 SUICIDAL IDEATION 1
369 SUICIDE ATTEMPT 1
370 SUSPECTED COUNTERFEIT PRODUCT 1
371 SUSPECTED OFF LABEL USE 1
372 SWELLING 1
373 SWELLING FACE 1
374 SYNCOPE 1
375 T-LYMPHOCYTE COUNT ABNORMAL 1
376 TASTE DISORDER 1
377 THERAPEUTIC PRODUCT EFFECT DECREASED 1
378 THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION 1
379 THERAPEUTIC RESPONSE DELAYED 1
380 THERAPY NON-RESPONDER 1
381 THROAT IRRITATION 1
382 THROMBOCYTOPENIA 1
383 TINEA PEDIS 1
384 TRANSIENT ISCHAEMIC ATTACK 1
385 TREATMENT NONCOMPLIANCE 1
386 TUMOUR MARKER INCREASED 1
387 UPPER LIMB FRACTURE 1
388 URETHRAL PAIN 1
389 URINARY HESITATION 1
390 URINARY RETENTION 1
391 URINARY TRACT INFECTION 1
392 URINE OUTPUT DECREASED 1
393 VAGINAL DISCHARGE 1
394 VISION BLURRED 1
395 VISUAL IMPAIRMENT 1
396 VITAMIN B12 DEFICIENCY 1
397 WEIGHT INCREASED 1
398 WRONG PRODUCT ADMINISTERED 1
399 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1